ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1661

CCR1 Potentiates Gouty Inflammation Following Initial CXCR2-Dependent Neutrophil Recruitment to Sites of Monosodium Urate Crystal Deposition in Mice

Robert P. Friday1, Terry K. Means2, Melissa Tai2, Christian D. Sadik2 and Andrew D. Luster3, 1Rheumatology, Massachusetts General Hospital, Boston, MA, 2Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Charlestown, MA, 3Massachusetts General Hospital, Charlestown, MA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: chemokines, Crystal-induced arthritis, gout and neutrophils

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cytokines, Mediators, and Gene Regulation II

Session Type: Abstract Submissions (ACR)

Background/Purpose: During attacks of acute gouty arthritis, monosodium urate (MSU) crystals elicit a potent neutrophilic inflammatory response in the affected joint, causing exquisite pain and often signs of systemic inflammation such as fever.  IL-1β plays a critical role in the development of gouty arthritis, as demonstrated by studies of IL-1β and NLRP3 knockout mice and the effectiveness of IL-1 blockade in treating or preventing gouty arthritis in humans.  However, mechanisms of neutrophil trafficking to sites of MSU crystal deposition during gouty inflammation have not been fully characterized, and our understanding of these pathways depends upon knowledge of the chemokine responses elicited by MSU crystals and their interface with chemotactic receptors on neutrophils.  Deletion of the chemokine receptor CXCR2 in mice has been shown to impair initiation of MSU crystal-induced inflammation in the air pouch model of gouty arthritis, but the other major murine neutrophil chemotactic receptors – CCR1, BLT1 and C5a – have not been systematically studied. 

Methods: Using the murine air pouch model of gouty arthritis, we have: (1) characterized the chemokine and cytokine profile of MSU crystal-induced inflammation using a multiplex bead immunoassay and (2) probed the time course of chemokine and cytokine production and neutrophil recruitment in CCR1-null, CXCR2-null, and CCR1-CXCR2 double knockout mice. 

Results: While our findings confirm that CXCR2 is critical for the initiation of neutrophilic inflammation in MSU crystal-challenged air pouches, mice lacking CCR1 also fail to achieve the expected maximal neutrophilic response to MSU crystal challenge (at 8 hours post crystal challenge).  Although CXCR2-null mice generate a very high level of KC and LIX (ligands for CXCR2) in the air pouch within 2 hours of MSU crystal challenge, MIP-1α and MIP-1β (ligands for CCR1), which typically appear 3-4 hours after crystal challenge, are not produced in these mice. 

Conclusion: We propose that CXCR2 and CCR1 act sequentially to initiate and potentiate neutrophil infiltration during gouty inflammation, with CCR1 chemokine ligand generation being dependent upon neutrophils entering the inflammatory site in response to CXCR2 chemokine signals.  These data broaden our understanding of coordinate chemokine-mediated neutrophil recruitment in a model of MSU crystal-induced arthritis and suggest that there may be a role for chemokine receptor modulation in the management of acute gouty arthritis in humans.


Disclosure:

R. P. Friday,
None;

T. K. Means,
None;

M. Tai,
None;

C. D. Sadik,
None;

A. D. Luster,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ccr1-potentiates-gouty-inflammation-following-initial-cxcr2-dependent-neutrophil-recruitment-to-sites-of-monosodium-urate-crystal-deposition-in-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology